ビスフォスフォネートの世界市場レポート 2025年

ビスフォスフォネート市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.5％で70億7,000万米ドルに成長します。予測期間中の成長は、骨健康調査への投資増加、手頃な価格の骨粗鬆症治療への需要増加、高齢者ヘルスケア重視の高まり、新興市場におけるビスフォスフォネートの使用拡大、デジタルヘルスキャンペーンによる認知度の高まりなどに起因すると考えられます。この期間に予想される主要動向には、ドラッグデリバリーシステムの革新、バイオアベイラビリティを高めた先進的製剤、併用療法の開発、患者アドヒアランス技術の進歩、個別化治療アプローチの進展などがあります。

骨粗鬆症の有病率の上昇は、今後数年間のビスフォスフォネート市場の成長を牽引すると予想されます。骨粗鬆症は、骨が弱くなり骨折しやすくなる病状です。骨粗鬆症は、加齢とともに骨密度が低下するため、世界的に高齢化が進んでいることに加え、生活習慣や適切な予防法が確立されていないことが主要原因となっています。ビスフォスフォネートは、骨粗鬆症の治療に有効で、骨の分解を遅らせることにより、骨を強化し、骨折リスクを低下させています。例えば、2024年8月、骨の健康調査とアドボカシーに焦点を当てた組織であるHealthy Bones Australiaは、2023年には骨粗鬆症と骨減少症に関連した骨折が推定19万3,482件あり、2033年には34％増の23万7,632件になるとの予測を報告しています。このように、骨粗鬆症の罹患率の上昇は、ビスフォスフォネート市場の成長を促進する重要な要因です。

調査と臨床検査の増加は、今後数年間のビスフォスフォネート市場の成長を促進すると予想されます。臨床検査とは、新しい治療法、医薬品、医療機器の安全性、有効性、潜在的な副作用を評価する、ヒトを対象とした調査研究です。この増加は、進化するヘルスケアニーズに対応し、患者の転帰を向上させるための革新的な治療法に対する需要の高まりが大きな要因となっています。ビスフォスフォネートの文脈では、臨床研究は、骨粗鬆症や骨転移のような状態の管理における有効性、安全性、長期的影響を調べることにより、骨の健康治療を進歩させる上で重要な役割を果たしています。例えば、2023年11月、英国を拠点とする団体である英国製薬工業協会（ABPI）は、英国における産業主導の臨床検査が4.3％増加し、2021年の394検査から2022年には411検査に増加したと報告しました。このように、調査と臨床検査への注目の高まりは、ビスフォスフォネート市場の拡大に大きく寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のビスフォスフォネート：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のビスフォスフォネート市場：成長率分析
• 世界のビスフォスフォネート市場の実績：規模と成長、2019～2024年
• 世界のビスフォスフォネート市場の予測：規模と成長、2024～2029年、2034年
• 世界のビスフォスフォネート：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のビスフォスフォネート市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アレンドロネート
• イバンドロネート
• リセドロネート
• ゾレドロン酸
• 世界のビスフォスフォネート市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 静脈内
• 皮下
• 骨内
• 筋肉内
• 世界のビスフォスフォネート市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• その他
• 世界のビスフォスフォネート市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 骨粗鬆症
• パジェット病
• 骨転移
• その他
• 世界のビスフォスフォネート市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 在宅ケア
• 医薬品小売
• 世界のビスフォスフォネート市場、アレンドロネートのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口錠
• 週ごとの配合
• ビタミンDとの組み合わせ
• ジェネリックアレンドロネート
• 世界のビスフォスフォネート市場、イバンドロネートのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口錠
• 月ごとの経口投与製剤
• 静脈注射
• ジェネリックイバンドロネート
• 世界のビスフォスフォネート市場、リセドロネートのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 即放錠
• 遅延放出錠
• 週ごとと月ごとの投与
• カルシウムとの組み合わせ
• 世界のビスフォスフォネート市場、ゾレドロン酸のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 静脈内注入
• 年間投与量
• 腫瘍学での使用
• 骨粗鬆症の使用
• ジェネリックゾレドロン酸

第7章 地域別・国別分析

• 世界のビスフォスフォネート市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のビスフォスフォネート市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ビスフォスフォネート市場：競合情勢
• ビスフォスフォネート市場：企業プロファイル
  • Pfizer Inc.
  • Roche Holding AG
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Bayer AG

第31章 その他の大手企業と革新的企業

• Novartis AG
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Organon & Co.
• Sun Pharmaceutical Industries Ltd.
• Apotex Inc.
• Aurobindo Pharma Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Alkem Laboratories
• Natco Pharma Ltd.
• Strides Pharma Science Limited
• Radius Health Inc.
• Warner Chilcott

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• ビスフォスフォネート市場、2029年：新たな機会を提供する国
• ビスフォスフォネート市場、2029年：新たな機会を提供するセグメント
• ビスフォスフォネート市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Bisphosphonates are a group of drugs that help prevent bone loss by inhibiting the activity of osteoclasts, making them a primary therapy for osteoporosis and other bone-weakening conditions. They are frequently prescribed to lower the risk of fractures in individuals with low bone density, Paget's disease, or bone metastases due to cancer. These medications aid in strengthening bones, increasing bone mineral density, and reducing fracture risk, especially in postmenopausal women and older adults.

The major types of bisphosphonates include alendronate, ibandronate, risedronate, and zoledronic acid. Alendronate is specifically used to treat and prevent bone-related disorders such as osteoporosis and Paget's disease. These drugs can be administered through various routes, including oral, intravenous, subcutaneous, intraosseous, and intramuscular. They are available through hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels. Primary applications include treating osteoporosis, Paget's disease, and bone metastases, with end users ranging from hospitals and clinics to homecare settings and pharmaceutical retailers.

The bisphosphonates market research report is one of a series of new reports from The Business Research Company that provides bisphosphonates market statistics, including bisphosphonates industry global market size, regional shares, competitors with a bisphosphonates market share, detailed bisphosphonates market segments, market trends and opportunities, and any further data you may need to thrive in the bisphosphonates industry. This bisphosphonates market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bisphosphonates market size has grown strongly in recent years. It will grow from $5.39 billion in 2024 to $5.70 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the increasing incidence of multiple myeloma, a rise in glucocorticoid-induced osteoporosis cases, the prevalence of sedentary lifestyles, greater availability of generic bisphosphonates, and the growing use of these medications in treating metastatic bone disease.

The bisphosphonates market size is expected to see strong growth in the next few years. It will grow to $7.07 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The projected growth in the forecast period can be attributed to increased investment in bone health research, rising demand for affordable osteoporosis treatments, a growing emphasis on elderly healthcare, expanding use of bisphosphonates in emerging markets, and heightened awareness driven by digital health campaigns. Key trends expected during this period include innovations in drug delivery systems, advanced formulations with enhanced bioavailability, the development of combination therapies, advancements in patient adherence technologies, and progress in personalized treatment approaches.

The rising prevalence of osteoporosis is expected to drive the growth of the bisphosphonates market in the coming years. Osteoporosis is a medical condition marked by weakened bones that are more susceptible to fractures. Its growing prevalence is mainly attributed to the aging global population, as bone density naturally declines with age, along with contributing lifestyle factors and a lack of adequate preventive measures. Bisphosphonates are effective in treating osteoporosis by slowing bone degradation, thereby strengthening bones and lowering fracture risk. For example, in August 2024, Healthy Bones Australia, an organization focused on bone health research and advocacy, reported that in 2023, there were an estimated 193,482 fractures linked to osteoporosis and osteopenia, with projections indicating a 34% increase to 237,632 fractures by 2033. Thus, the rising incidence of osteoporosis is a key factor fueling the growth of the bisphosphonates market.

The rise in research and clinical trials is expected to drive the growth of the bisphosphonates market in the coming years. Clinical trials are research studies involving human participants that assess the safety, effectiveness, and potential side effects of new treatments, drugs, or medical devices. This increase is largely fueled by the growing demand for innovative therapies to meet evolving healthcare needs and enhance patient outcomes. In the context of bisphosphonates, clinical research plays a critical role in advancing bone health treatments by examining their efficacy, safety, and long-term impact in managing conditions like osteoporosis and bone metastases. For example, in November 2023, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported a 4.3% increase in industry-initiated clinical trials in the UK, rising from 394 trials in 2021 to 411 in 2022. Thus, the growing focus on research and clinical trials is contributing significantly to the expansion of the bisphosphonates market.

In May 2023, Abiogen Pharma S.p.A., an Italy-based pharmaceutical company, acquired EffRx Pharmaceuticals SA for an undisclosed amount. This acquisition is intended to strategically enhance and diversify Abiogen's rare disease portfolio by incorporating EffRx's innovative therapies for musculoskeletal and rare conditions. It also supports Abiogen's goal of expanding its international footprint and strengthening its capabilities in the development and commercialization of specialized treatments worldwide. EffRx Pharmaceuticals SA is a Switzerland-based specialty pharmaceutical company that produces and markets bisphosphonates for the treatment of osteoporosis.

Major players in the bisphosphonates market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Organon & Co., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Natco Pharma Ltd., Strides Pharma Science Limited, Radius Health Inc., Warner Chilcott.

North America was the largest region in the bisphosphonates market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bisphosphonates report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bisphosphonates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bisphosphonates market consists of sales of oral tablets, bisphosphonate capsules, bisphosphonate injections, oral solutions, and intravenous (IV) infusions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bisphosphonates Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bisphosphonates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bisphosphonates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bisphosphonates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
• 2) By Route Of Administration: Oral; Intravenous; Subcutaneous; Intraosseous; Intramuscular
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 4) By Application: Osteoporosis; Paget's Disease; Bone Metastasis; Other Application
• 5) By End-User: Hospitals; Clinics; Homecare Settings; Pharmaceutical Retail
• Subsegments:
• 1) By Alendronate: Oral Tablets; Once-Weekly Formulation; Combination With Vitamin D; Generic Alendronate
• 2) By Ibandronate: Oral Tablets; Monthly Oral Formulation; Intravenous Injection; Generic Ibandronate
• 3) By Risedronate: Immediate-Release Tablets; Delayed-Release Tablets; Weekly And Monthly Dosing; Combination With Calcium
• 4) By Zoledronic Acid: Intravenous Infusion; Annual Dosing; Oncology Use; Osteoporosis Use; Generic Zoledronic Acid
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bisphosphonates Market Characteristics

3. Bisphosphonates Market Trends And Strategies

4. Bisphosphonates Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bisphosphonates Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bisphosphonates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bisphosphonates Market Growth Rate Analysis
• 5.4. Global Bisphosphonates Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bisphosphonates Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bisphosphonates Total Addressable Market (TAM)

6. Bisphosphonates Market Segmentation

• 6.1. Global Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alendronate
• Ibandronate
• Risedronate
• Zoledronic Acid
• 6.2. Global Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• Intraosseous
• Intramuscular
• 6.3. Global Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Bisphosphonates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Osteoporosis
• Paget's Disease
• Bone Metastasis
• Other Application
• 6.5. Global Bisphosphonates Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare Settings
• Pharmaceutical Retail
• 6.6. Global Bisphosphonates Market, Sub-Segmentation Of Alendronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablets
• Once-Weekly Formulation
• Combination With Vitamin D
• Generic Alendronate
• 6.7. Global Bisphosphonates Market, Sub-Segmentation Of Ibandronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablets
• Monthly Oral Formulation
• Intravenous Injection
• Generic Ibandronate
• 6.8. Global Bisphosphonates Market, Sub-Segmentation Of Risedronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Tablets
• Delayed-Release Tablets
• Weekly And Monthly Dosing
• Combination With Calcium
• 6.9. Global Bisphosphonates Market, Sub-Segmentation Of Zoledronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Infusion
• Annual Dosing
• Oncology Use
• Osteoporosis Use
• Generic Zoledronic Acid

7. Bisphosphonates Market Regional And Country Analysis

• 7.1. Global Bisphosphonates Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bisphosphonates Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bisphosphonates Market

• 8.1. Asia-Pacific Bisphosphonates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bisphosphonates Market

• 9.1. China Bisphosphonates Market Overview
• 9.2. China Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bisphosphonates Market

• 10.1. India Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bisphosphonates Market

• 11.1. Japan Bisphosphonates Market Overview
• 11.2. Japan Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bisphosphonates Market

• 12.1. Australia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bisphosphonates Market

• 13.1. Indonesia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bisphosphonates Market

• 14.1. South Korea Bisphosphonates Market Overview
• 14.2. South Korea Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bisphosphonates Market

• 15.1. Western Europe Bisphosphonates Market Overview
• 15.2. Western Europe Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bisphosphonates Market

• 16.1. UK Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bisphosphonates Market

• 17.1. Germany Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bisphosphonates Market

• 18.1. France Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bisphosphonates Market

• 19.1. Italy Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bisphosphonates Market

• 20.1. Spain Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bisphosphonates Market

• 21.1. Eastern Europe Bisphosphonates Market Overview
• 21.2. Eastern Europe Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bisphosphonates Market

• 22.1. Russia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bisphosphonates Market

• 23.1. North America Bisphosphonates Market Overview
• 23.2. North America Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bisphosphonates Market

• 24.1. USA Bisphosphonates Market Overview
• 24.2. USA Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bisphosphonates Market

• 25.1. Canada Bisphosphonates Market Overview
• 25.2. Canada Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bisphosphonates Market

• 26.1. South America Bisphosphonates Market Overview
• 26.2. South America Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bisphosphonates Market

• 27.1. Brazil Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bisphosphonates Market

• 28.1. Middle East Bisphosphonates Market Overview
• 28.2. Middle East Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bisphosphonates Market

• 29.1. Africa Bisphosphonates Market Overview
• 29.2. Africa Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bisphosphonates Market Competitive Landscape And Company Profiles

• 30.1. Bisphosphonates Market Competitive Landscape
• 30.2. Bisphosphonates Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Bisphosphonates Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Eli Lilly and Company
• 31.3. Amgen Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Organon & Co.
• 31.6. Sun Pharmaceutical Industries Ltd.
• 31.7. Apotex Inc.
• 31.8. Aurobindo Pharma Ltd.
• 31.9. Dr. Reddy's Laboratories Ltd.
• 31.10. Cipla Ltd.
• 31.11. Alkem Laboratories
• 31.12. Natco Pharma Ltd.
• 31.13. Strides Pharma Science Limited
• 31.14. Radius Health Inc.
• 31.15. Warner Chilcott

32. Global Bisphosphonates Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bisphosphonates Market

34. Recent Developments In The Bisphosphonates Market

35. Bisphosphonates Market High Potential Countries, Segments and Strategies

• 35.1 Bisphosphonates Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bisphosphonates Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bisphosphonates Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer